{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:00:05Z","timestamp":1794243605141,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82002161"],"award-info":[{"award-number":["82002161"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The protozoan parasite <jats:italic>Toxoplasma gondii<\/jats:italic> is a major concern for human and animal health. Although the metabolic understanding of toxoplasmosis has increased in recent years, the analysis of metabolic alterations through noninvasive methodologies in biofluids remains limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Here, we applied liquid chromatography-tandem mass spectrometry (LC-MS\/MS)-based metabolomics and multivariate statistical analysis to analyze BALB\/c mouse urine collected from acutely infected, chronically infected and control subjects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, we identified 2065 and 1409 metabolites in the positive electrospray ionization (ESI\u2009+) mode and ESI\u00a0\u2212 mode, respectively. Metabolomic patterns generated from principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) score plots clearly separated <jats:italic>T. gondii<\/jats:italic>-infected from uninfected urine samples. Metabolites with altered levels in urine from <jats:italic>T. gondii<\/jats:italic>-infected mice revealed changes in pathways related to amino acid metabolism, fatty acid metabolism, and nicotinate and nicotinamide metabolism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first study to our knowledge on urine metabolic profiling of BALB\/c mouse with <jats:italic>T. gondii<\/jats:italic> infection. The urine metabolome of infected mouse is distinctive and has value in the understanding of <jats:italic>Toxoplasmosis<\/jats:italic> pathogenesis and improvement of treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-022-05408-2","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T17:03:48Z","timestamp":1659114228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Investigation of urine metabolome of BALB\/c mouse infected with an avirulent strain of Toxoplasma gondii"],"prefix":"10.1186","volume":"15","author":[{"given":"Chun-Xue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-Qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Dian","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"5408_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30:1217\u201358.","journal-title":"Int J Parasitol"},{"key":"5408_CR2","first-page":"e00115","volume":"34","author":"HM Elsheikha","year":"2020","unstructured":"Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis. Clin Microbiol. 2020;34:e00115-e119.","journal-title":"Clin Microbiol"},{"key":"5408_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpara.2020.11.001","volume":"51","author":"NC Smith","year":"2021","unstructured":"Smith NC, Goulart C, Hayward JA, Kupz A, Miller CM, van Dooren GG. Control of human toxoplasmosis. Int J Parasitol. 2021;51:95\u2013121.","journal-title":"Int J Parasitol"},{"key":"5408_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","volume":"39","author":"LM Weiss","year":"2009","unstructured":"Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol. 2009;39:895\u2013901.","journal-title":"Int J Parasitol"},{"key":"5408_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1046\/j.1469-0691.2002.00485.x","volume":"8","author":"D Hill","year":"2002","unstructured":"Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002;8:634\u201340.","journal-title":"Clin Microbiol Infect"},{"key":"5408_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/157.1.1","volume":"157","author":"BJ Luft","year":"1988","unstructured":"Luft BJ, Remington JS. AIDS commentary. Toxoplasmic encephalitis. J Infect Dis. 1988;157:1\u20136.","journal-title":"J Infect Dis"},{"key":"5408_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.amjmed.2004.08.023","volume":"118","author":"JD Kravetz","year":"2005","unstructured":"Kravetz JD, Federman DG. Toxoplasmosis in pregnancy. The Am J Med. 2005;118:212\u20136.","journal-title":"The Am J Med"},{"key":"5408_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/vaccines9050413","volume":"9","author":"KB Chu","year":"2021","unstructured":"Chu KB, Quan FS. Advances in Toxoplasma gondii vaccines: current strategies and challenges for vaccine development. Vaccines (Basel). 2021;9:413.","journal-title":"Vaccines (Basel)"},{"key":"5408_CR9","doi-asserted-by":"publisher","first-page":"111711","DOI":"10.1016\/j.ejmech.2019.111711","volume":"183","author":"Y Deng","year":"2019","unstructured":"Deng Y, Wu T, Zhai SQ, Li CH. Recent progress on anti-Toxoplasma drugs discovery: design, synthesis and screening. Eur J Med Chem. 2019;183:111711.","journal-title":"Eur J Med Chem"},{"key":"5408_CR10","doi-asserted-by":"publisher","first-page":"e20163860","DOI":"10.1542\/peds.2016-3860","volume":"139","author":"YA Maldonado","year":"2017","unstructured":"Maldonado YA, Read JS. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139:e20163860.","journal-title":"Pediatrics"},{"key":"5408_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13071-015-0902-6","volume":"8","author":"Q Liu","year":"2015","unstructured":"Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015;8:292.","journal-title":"Parasit Vectors"},{"key":"5408_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13071-019-3623-4","volume":"12","author":"J Ma","year":"2019","unstructured":"Ma J, He JJ, Hou JL, Zhou CX, Zhang FK, Elsheikha HM, et al. Metabolomic signature of mouse cerebral cortex following Toxoplasma gondii infection. Parasit Vectors. 2019;12:373.","journal-title":"Parasit Vectors"},{"key":"5408_CR13","doi-asserted-by":"publisher","first-page":"e1008432","DOI":"10.1371\/journal.ppat.1008432","volume":"16","author":"WJ Olson","year":"2020","unstructured":"Olson WJ, Martorelli Di Genova B, Gallego-Lopez G, Dawson AR, Stevenson D, Amador-Noguez D, et al. Dual metabolomic profiling uncovers Toxoplasma manipulation of the host metabolome and the discovery of a novel parasite metabolic capability. PLoS Pathog. 2020;16:e1008432.","journal-title":"PLoS Pathog"},{"key":"5408_CR14","doi-asserted-by":"publisher","first-page":"19557","DOI":"10.1038\/srep19557","volume":"6","author":"CX Zhou","year":"2016","unstructured":"Zhou CX, Zhou DH, Elsheikha HM, Zhao Y, Suo X, Zhu XQ. Metabolomic profiling of mice serum during toxoplasmosis progression using liquid chromatography-mass spectrometry. Sci Rep. 2016;6:19557.","journal-title":"Sci Rep"},{"key":"5408_CR15","doi-asserted-by":"publisher","first-page":"110271","DOI":"10.1016\/j.celrep.2021.110271","volume":"38","author":"X Bi","year":"2022","unstructured":"Bi X, Liu W, Ding X, Liang S, Zheng Y, Zhu X, et al. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Rep. 2022;38:110271.","journal-title":"Cell Rep"},{"key":"5408_CR16","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.1038\/s41598-018-29713-y","volume":"8","author":"A Pegalajar-Jurado","year":"2018","unstructured":"Pegalajar-Jurado A, Fitzgerald BL, Islam MN, Belisle JT, Wormser GP, Waller KS, et al. Identification of urine metabolites as biomarkers of early Lyme disease. Sci Rep. 2018;8:12204.","journal-title":"Sci Rep"},{"key":"5408_CR17","doi-asserted-by":"publisher","first-page":"102239","DOI":"10.1016\/j.parint.2020.102239","volume":"80","author":"RM Loyo","year":"2021","unstructured":"Loyo RM, Zarate E, Barbosa CS, Simoes-Barbosa A. Gas chromatography-mass spectrometry (GC\/MS) reveals urine metabolites associated to light and heavy infections by Schistosoma mansoni in mice. Parasitol Int. 2021;80:102239.","journal-title":"Parasitol Int"},{"key":"5408_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13071-021-04713-6","volume":"14","author":"LL Cui","year":"2021","unstructured":"Cui LL, Zhou CX, Han B, Wang SS, Li SY, Xie SC, et al. Urine proteomics for profiling of mouse toxoplasmosis using liquid chromatography tandem mass spectrometry analysis. Parasit Vectors. 2021;14:211.","journal-title":"Parasit Vectors"},{"key":"5408_CR19","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1007\/s00216-013-6934-x","volume":"405","author":"P Emond","year":"2013","unstructured":"Emond P, Mavel S, A\u00efdoud N, Nadal-Desbarats L, Montigny F, Bonnet-Brilhault F, et al. GC-MS-based urine metabolic profiling of autism spectrum disorders. Anal Bioanal Chem. 2013;405:5291\u2013300.","journal-title":"Anal Bioanal Chem"},{"key":"5408_CR20","doi-asserted-by":"publisher","first-page":"22525","DOI":"10.1038\/srep22525","volume":"6","author":"Q Feng","year":"2016","unstructured":"Feng Q, Liu Z, Zhong S, Li R, Xia H, Jie Z, et al. Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease. Sci Rep. 2016;6:22525.","journal-title":"Sci Rep"},{"key":"5408_CR21","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49:W388\u201396.","journal-title":"Nucleic Acids Res"},{"key":"5408_CR22","first-page":"D440","volume":"48","author":"K Haug","year":"2020","unstructured":"Haug K, Cochrane K, Nainala VC, Williams M, Chang J, Jayaseelan KV, et al. MetaboLights: a resource evolving in response to the needs of its scientific community. Nucleic Acids Res. 2020;48:D440\u20134.","journal-title":"Nucleic Acids Res"},{"key":"5408_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1074\/mcp.M115.052381","volume":"15","author":"S Ren","year":"2016","unstructured":"Ren S, Shao Y, Zhao X, Hong CS, Wang F, Lu X, et al. Integration of metabolomics and transcriptomics reveals major metabolic pathways and potential biomarker involved in prostate cancer. Mol Cell Proteomics. 2016;15:154\u201363.","journal-title":"Mol Cell Proteomics"},{"key":"5408_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cmet.2020.06.016","volume":"32","author":"JW Song","year":"2020","unstructured":"Song JW, Lam SM, Fan X, Cao WJ, Wang SY, Tian H, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020;32:188\u2013202.","journal-title":"Cell Metab"},{"key":"5408_CR25","doi-asserted-by":"publisher","first-page":"626183","DOI":"10.3389\/fmicb.2020.626183","volume":"11","author":"X Yu","year":"2021","unstructured":"Yu X, Feng G, Zhang Q, Cao J. From metabolite to metabolome: metabolomics applications in Plasmodium Research. Front Microbiol. 2021;11:626183.","journal-title":"Front Microbiol"},{"key":"5408_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1021\/pr100835s","volume":"10","author":"N Nagaraj","year":"2011","unstructured":"Nagaraj N, Mann M. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res. 2011;10:637\u201345.","journal-title":"J Proteome Res"},{"key":"5408_CR27","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.3389\/fmicb.2017.02612","volume":"8","author":"CX Zhou","year":"2018","unstructured":"Zhou CX, Cong W, Chen XQ, He SY, Elsheikha HM, Zhu XQ. Serum metabolic profiling of oocyst-induced Toxoplasma gondii acute and chronic infections in mice using mass-spectrometry. Front Microbiol. 2018;8:2612.","journal-title":"Front Microbiol"},{"key":"5408_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nri3598","volume":"14","author":"F Yarovinsky","year":"2014","unstructured":"Yarovinsky F. Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol. 2014;14:109\u201321.","journal-title":"Nat Rev Immunol"},{"key":"5408_CR29","doi-asserted-by":"publisher","first-page":"97008","DOI":"10.1289\/EHP4713","volume":"127","author":"DK Barupal","year":"2019","unstructured":"Barupal DK, Fiehn O. Generating the blood exposome database using a comprehensive text mining and database fusion approach. Environ Health Perspect. 2019;127:97008.","journal-title":"Environ Health Perspect"},{"key":"5408_CR30","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1021\/acs.jproteome.7b00206","volume":"16","author":"J Yu","year":"2017","unstructured":"Yu J, Kong L, Zhang A, Han Y, Liu Z, Sun H, et al. High-throughput metabolomics for discovering potential metabolite biomarkers and metabolic mechanism from the APPswe\/PS1dE9 transgenic model of Alzheimer\u2019s disease. J Proteome Res. 2017;16:3219\u201328.","journal-title":"J Proteome Res"},{"key":"5408_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jpba.2011.11.010","volume":"60","author":"T Zhao","year":"2012","unstructured":"Zhao T, Zhang H, Zhao T, Zhang X, Lu J, Yin T, et al. Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease. J Pharm Biomed Anal. 2012;60:32\u201343.","journal-title":"J Pharm Biomed Anal"},{"key":"5408_CR32","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/jphp.12081","volume":"65","author":"BR Pinho","year":"2013","unstructured":"Pinho BR, Ferreres F, Valent\u00e3o P, Andrade PB. Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer\u2019s disease treatment. J Pharm Pharmacol. 2013;65:1681\u2013700.","journal-title":"J Pharm Pharmacol"},{"key":"5408_CR33","doi-asserted-by":"publisher","first-page":"113376","DOI":"10.1016\/j.jpba.2020.113376","volume":"188","author":"Y Fan","year":"2020","unstructured":"Fan Y, Zhao L, Huang X, Jia Q, Wang W, Gao M, et al. Pharmacokinetic and bioavailability studies of \u03b1-viniferin after intravenous and oral administration to rats. J Pharm Biomed Anal. 2020;188:113376.","journal-title":"J Pharm Biomed Anal"},{"key":"5408_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1046\/j.1537-2995.1975.15275122804.x","volume":"15","author":"GJ Roth","year":"1975","unstructured":"Roth GJ, Moore GL, Kline WE, Poskitt TR. The renal effect of intravenous adenine in humans. Transfusion. 1975;15:116\u201323.","journal-title":"Transfusion"},{"key":"5408_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000058406","volume":"91","author":"EM Slominska","year":"2002","unstructured":"Slominska EM, Szolkiewicz M, Smolenski RT, Rutkowski B, Swierczynski J. High plasma adenine concentration in chronic renal failure and its relation to erythrocyte ATP. Nephron. 2002;91:286\u201391.","journal-title":"Nephron"},{"key":"5408_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1440-1797.2010.01387.x","volume":"16","author":"K Doi","year":"2011","unstructured":"Doi K, Hamasaki Y, Noiri E, Nosaka K, Suzuki T, Toda A, et al. Role of leukotriene B4 in accelerated hyperlipidaemic renal injury. Nephrology (Carlton). 2011;16:304\u20139.","journal-title":"Nephrology (Carlton)"},{"key":"5408_CR37","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1021\/pr300337s","volume":"11","author":"X Wang","year":"2012","unstructured":"Wang X, Wang X, Xie G, Zhou M, Yu H, Lin Y, et al. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients. J Proteome Res. 2012;11:3838\u201347.","journal-title":"J Proteome Res"},{"key":"5408_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12876-018-0842-7","volume":"18","author":"Z Liu","year":"2018","unstructured":"Liu Z, Zhang Z, Huang M, Sun X, Liu B, Guo Q, et al. Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments. BMC Gastroenterol. 2018;18:112.","journal-title":"BMC Gastroenterol"},{"key":"5408_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1475-2875-9-110","volume":"9","author":"A Basant","year":"2010","unstructured":"Basant A, Rege M, Sharma S, Sonawat HM. Alterations in urine, serum and brain metabolomic profiles exhibit sexual dimorphism during malaria disease progression. Malar J. 2010;9:110.","journal-title":"Malar J"},{"key":"5408_CR40","first-page":"611","volume":"152","author":"LA Sanni","year":"1998","unstructured":"Sanni LA, Thomas SR, Tattam BN, Moore DE, Chaudhri G, Stocker R, et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol. 1998;152:611\u20139.","journal-title":"Am J Pathol"},{"key":"5408_CR41","doi-asserted-by":"publisher","first-page":"569727","DOI":"10.3389\/fimmu.2020.569727","volume":"11","author":"Y Hu","year":"2020","unstructured":"Hu Y, Chen J, Xu Y, Zhou H, Huang P, Ma Y, et al. Alterations of gut microbiome and metabolite profiling in mice infected by Schistosoma japonicum. Front Immunol. 2020;11:569727.","journal-title":"Front Immunol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05408-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-022-05408-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05408-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T19:06:20Z","timestamp":1659121580000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-022-05408-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5408"],"URL":"https:\/\/doi.org\/10.1186\/s13071-022-05408-2","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"26 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments used in this study were approved by the Research Ethics Committee of Shandong University (ECSBMSSDU2020-2-027). The maintenance and care of experimental animals were carried out in strict accordance with the regulations of Good Animal Practice requirements of the Animal Ethics Procedures and Guidelines of the People\u2019s Republic of China. All efforts have been made to alleviate suffering and minimize the number of animals used in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}